Cargando…

Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients

OBJECTIVES: Focusing on the advanced non-small cell lung cancer (NSCLC) patients without driver mutations can elucidate the clinical impact of COPD on treatment outcomes. The present study evaluated the effects of COPD on the overall survival of driver mutation-negative NSCLC patients undergoing con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Jeong Uk, Yeo, Chang Dong, Rhee, Chin Kook, Kim, Yong Hyun, Park, Chan Kwon, Kim, Ju Sang, Kim, Jin Woo, Kim, Seung Joon, Yoon, Hyoung Kyu, Lee, Sang Haak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047599/ https://www.ncbi.nlm.nih.gov/pubmed/30034229 http://dx.doi.org/10.2147/COPD.S167372

Ejemplares similares

Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations
por: Lim, Jeong Uk, et al.
Publicado: (2015)

Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer
por: Ban, Wooho, et al.
Publicado: (2016)

Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Jo, Hyunji, et al.
Publicado: (2022)

A Case of Residual Non-Small Cell Lung Cancer Cells Coexisting With Newly Developed Small Cell Lung Cancer Cells in Ascitic Fluid after Chemotherapy for Non-Small Cell Lung Cancer
por: Park, Sang Hyuk, et al.
Publicado: (2014)

Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
por: Ban, Woo Ho, et al.
Publicado: (2020)

Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion
por: Lim, Jeong Uk, et al.
Publicado: (2018)

Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Association between clinical outcomes and local treatment in stage IV non‐small cell lung cancer patients with single extrathoracic metastasis
por: Lim, Jeong Uk, et al.
Publicado: (2022)

The Value of Residual Volume/Total Lung Capacity as an Indicator for Predicting Postoperative Lung Function in Non-Small Lung Cancer
por: Kwon, Oh-Beom, et al.
Publicado: (2021)

Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Characteristics and clinical outcomes of patients with nonsmoking small cell lung cancer in Korea
por: Kang, Hye Seon, et al.
Publicado: (2022)

Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD: a cohort study
por: Kang, Noeul, et al.
Publicado: (2020)

ZNF143 Expression is Associated with COPD and Tumor Microenvironment in Non-Small Cell Lung Cancer
por: Feng, Zhenxing, et al.
Publicado: (2022)

Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD
por: Dong, Weigang, et al.
Publicado: (2018)

Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer
por: Yi, Young-Soo, et al.
Publicado: (2018)

Natural course of early COPD
por: Rhee, Chin Kook, et al.
Publicado: (2017)

SBRT Treatment of Metachronous Small-Cell and Non-Small-Cell Lung Carcinomas in a Patient with Severe COPD
por: Duimering, Adele, et al.
Publicado: (2015)

Clinical significance of anemia as a prognostic factor in non-small cell lung cancer carcinoma with activating epidermal growth factor receptor mutations
por: Kang, Hye Seon, et al.
Publicado: (2020)

Spirometry at diagnosis and overall survival in non‐small cell lung cancer patients
por: Zhai, Ting, et al.
Publicado: (2022)

Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?
por: Polverino, Francesca, et al.
Publicado: (2016)

New Targeted Therapy for Non-Small Cell Lung Cancer
por: Chung, Eun Ki, et al.
Publicado: (2023)

Pazopanib for Non-small Cell Lung Cancer: The First Case Report in Korea
por: Jo, Jaemin, et al.
Publicado: (2016)

Non-small Cell Lung Cancer Initially Presenting with Intracardiac Metastasis
por: Kim, Jung Han, et al.
Publicado: (2005)

Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy
por: Nam, Jung Hyun, et al.
Publicado: (2023)

Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy
por: Omote, Norihito, et al.
Publicado: (2017)

The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential biomarker
por: Kim, Seohyun, et al.
Publicado: (2023)

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
por: Lim, Sun Min, et al.
Publicado: (2020)

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
por: Cho, Su Han, et al.
Publicado: (2021)

Predictors of Recurrence after Curative Resection in Patients with Early-Stage Non-Small Cell Lung Cancer
por: Lee, Sang Hee, et al.
Publicado: (2015)

Association between Temporal Muscle Thickness and Overall Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis
por: Kim, Young Il, et al.
Publicado: (2022)

Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of Metastasis
por: Lee, Dong Soo, et al.
Publicado: (2013)

Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer
por: Kim, Seung Tae, et al.
Publicado: (2012)

Efficacy of Surgical Treatment for Brain Metastasis in Patients with Non-Small Cell Lung Cancer
por: Kim, Sang Young, et al.
Publicado: (2015)

Prognosis of pulmonary lymphangitic carcinomatosis in patients with non-small cell lung cancer
por: Im, Yunjoo, et al.
Publicado: (2021)

Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD
por: Rhee, Chin Kook, et al.
Publicado: (2015)

Clinical characteristics of miliary pulmonary metastases in non‐small cell lung cancer
por: Choi, Hanmil, et al.
Publicado: (2023)

Bowel Perforation after Erlotinib Treatment in a Patient with Non-Small Cell Lung Cancer
por: Cheon, Yun-Hong, et al.
Publicado: (2011)

Driver oncogenes in Sub-Saharan African patients with non-small cell lung cancer
por: Legius, Barbara, et al.
Publicado: (2016)

Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer
por: Si, Xiaoyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_laj1fkl9lpbaqjgvm64p6cqk3p